Skip to main content

SpringWorks Therapeutics, Inc.

SWTXDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001773427

SpringWorks Therapeutics, Inc. was delisted in 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.68B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q2 2026

Institutional positions in SpringWorks Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

SWTX is no longer listed, and 13F filings after Q2 2025 list far fewer holders. See Q2 2025

Institutional holders
1
0 vs. Q1 2026
Shares held
1
0 (0.0%) vs. Q1 2026
Total value
$47
$0 (0.0%) vs. Q1 2026
New holders
0
0 more added
Sold out
0
0 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 1 institution
Q1 2021: 137 institutionsQ2 2021: 134 institutionsQ3 2021: 142 institutionsQ4 2021: 144 institutionsQ1 2022: 136 institutionsQ2 2022: 144 institutionsQ3 2022: 148 institutionsQ4 2022: 137 institutionsQ1 2023: 148 institutionsQ2 2023: 142 institutionsQ3 2023: 147 institutionsQ4 2023: 180 institutionsQ1 2024: 217 institutionsQ2 2024: 209 institutionsQ3 2024: 226 institutionsQ4 2024: 216 institutionsQ1 2025: 306 institutionsQ2 2025: 223 institutionsQ3 2025: 4 institutionsQ4 2025: 2 institutionsQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ2 2026: $47
Q1 2021: $3.23BQ2 2021: $4.10BQ3 2021: $2.86BQ4 2021: $3.12BQ1 2022: $2.80BQ2 2022: $1.38BQ3 2022: $1.80BQ4 2022: $1.73BQ1 2023: $1.94BQ2 2023: $1.82BQ3 2023: $1.58BQ4 2023: $2.79BQ1 2024: $4.05BQ2 2024: $3.00BQ3 2024: $2.60BQ4 2024: $2.92BQ1 2025: $3.33BQ2 2025: $3.68BQ3 2025: $2.39MQ4 2025: $2.18MQ1 2026: $47Q2 2026: $47
Institutions holding SWTX and their total value by quarter
QuarterHoldersValue
Q2 20261$47
Q1 20261$47
Q4 20252$2.18M
Q3 20254$2.39M
Q2 2025223$3.68B
Q1 2025306$3.33B
Q4 2024216$2.92B
Q3 2024226$2.60B
Q2 2024209$3.00B
Q1 2024217$4.05B
Q4 2023180$2.79B
Q3 2023147$1.58B
Q2 2023142$1.82B
Q1 2023148$1.94B
Q4 2022137$1.73B
Q3 2022148$1.80B
Q2 2022144$1.38B
Q1 2022136$2.80B
Q4 2021144$3.12B
Q3 2021142$2.86B
Q2 2021134$4.10B
Q1 2021137$3.23B

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding SpringWorks Therapeutics, Inc.; share changes are against Q1 2026.

Institutions holding SWTX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Huntington National Bank1$470.00%00.0%Unchanged